Michele Tavecchio (Former)
1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networks
(
- Contribution to journal › Article
-
Mark
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin
(
- Contribution to journal › Article
- 2013
-
Mark
Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility
(
- Contribution to journal › Article
- 2012
-
Mark
Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer
(
- Contribution to journal › Article
-
Mark
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K
(
- Contribution to journal › Article
-
Mark
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
(
- Contribution to journal › Article
- 2011
-
Mark
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
(
- Contribution to journal › Article
- 2010
-
Mark
Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells
(
- Contribution to journal › Article
-
Mark
The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo
(
- Contribution to journal › Article
- 2009
-
Mark
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
(
- Contribution to journal › Article